News
- Nitrosamines: EMA aligns recommendations for sartans with those for other medicines
- WHO establishes Council on the Economics of Health for All
- The clinical study of NO-mediated Vascular Function in Covid-19 Patient begins in Italy
- Cancer research institute launches a master protocol empowering mechanobiology translation research in Breast Cancer
- University hospital evaluates сoagulopathy and мasculopathy as a predictor of the severity of SARS-CoV-2 / COVID-19 infection
- Pharmaceutical company assesses skin irritation and sensitization for HP-1050 patch
- Research Hospital started a new clinical trial of Immune Response evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer patients treated with SBRT
- Glaukos Corporation evaluates the rate of clinically relevant complications associated with iStent inject
- Neglected tropical diseases: World Health Assembly endorses bold new road map targets for 2030
- UNICEF and PAHO launch joint COVID-19 vaccine tender on behalf of COVAX Facility
- WHO HTS Info app
- Hydroxychloroquine does not benefit adults hospitalized with COVID-19
- Nearly 1 in 5 COVID-19 deaths in the African region linked to diabetes
- Updated dashboard supports differentiated HIV testing services
- PAHO outlines best practices to control COVID-19 pandemic
- Cross-disciplinary team will design, develop devices to better treat spinal cord injuries
- Czech National Institute of Mental Health consider virtual tasks vs paper-pencil methods in cognitive rehabilitation in patients with Schizophrenia and Depression
- University of Leipzig conducts Analysis of Mental Disorders, Psychosocial Distress and Psycho-oncological Care Needs of Patients and Their Relatives
- University of Washington conducts clinical trial of Glargine to Degludec Insulin Transition
- The effect of low-volume training and resistance exercise in individual with Stroke
- Private research university is using Smart Watches to detect and monitor COVID-19
- Pharmaceutical enterprise evaluates the efficacy of Nafabelltan in hospitalized patients diagnosed with COVID-19 pneumonia
- Pharmaceutical company started a new clinical trial of Masitinib combined with Isoquercetin in hospitalized patients with COVID-19
- Italian company conducts clinical trial of plasmApuane CoV-2
- Biotechnology company started first-in-human study of IMGC936 in patients with advanced Solid Tumors
Clinical Research News
Připravované klinické studie
-
Aperta Biosciences, LLCZatím nenabíráme
-
Hospices Civils de LyonZatím nenabírámeÚnik moči | Neurogenní močový měchýř | Odklon moči | Malignita pánve | Karcinom močového měchýřeFrancie
-
Second Affiliated Hospital, Zhejiang University...NáborNormální sluch | Vystavení hluku | Preferred Loudness LevelČína
-
Qilu Pharmaceutical Co., Ltd.Zatím nenabírámeClear Cell Renal Cell Carcinoma | Rakovina vaječníků | Jiné pokročilé solidní nádoryČína
-
University Hospital, AntwerpZatím nenabírámeNekrotizující enterokolitida novorozenců | Neonatální sepse s pozdním nástupemBelgie, Holandsko
-
VA Office of Research and DevelopmentZatím nenabírámeMetastatický nemalobuněčný karcinom plic | Cancer-Associated Weight Loss | Elevated Inflammatory MarkersSpojené státy
-
ENTire Medical Ltd.Zatím nenabírámeHypertrofie | Tonzilektomie | Obstrukce dýchacích cest Horní | Adenoidektomická chirurgieSpojené státy
-
AbbVieZatím nenabírámeStředně těžká až těžká psoriáza
-
Institute of Hematology & Blood Diseases Hospital...NáborAplastická anémie | Klonální hematopoéza | Imunosupresivní terapieČína
-
Ahmed Nasser Ali MabkhoutNáborČelistní cysty | Alveolar Bone DefectsJemen
-
University of CoimbraZatím nenabíráme
-
AbbVieZatím nenabíráme
